SynCo Bio Partners will provide process validation and GMP commercial manufacturing services to support the commercial launch of two separate biopharmaceutical products, from an unnamed company, for the US market. The recombinant proteins will be produced in E. coli.
SynCo BioPartners
Tuesday 2 February 2010
SynCo signs US deal
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment